Omalizumab



Omalizumab





See Appendix R, Less commonly used drugs.


Omega-3-Acid Ethyl Esters

(oh may gah-three-ass’ id)

Lovaza

PREGNANCY CATEGORY C


Drug Classes

Lipid-lowering drug

Omega-3 fatty acid


Therapeutic Actions

Inhibits liver enzyme systems leading to a decrease in the synthesis of triglycerides in the liver, lowering serum triglyceride levels.


Indications



  • As an adjunct to diet to reduce very high (greater than 500 mg/dL) triglyceride levels in adult patients



Available Forms

Capsules—1 g


Dosages

Adults

4 g/day PO taken as a single dose (4 capsules) or divided into two doses—2 capsules PO bid.

Pediatric patients

Safety and efficacy not established.


Pharmacokinetics















Route Onset Peak
Oral Rapid Unknown

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Omalizumab

Full access? Get Clinical Tree

Get Clinical Tree app for offline access